Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Richard K. Valicenti"'
Autor:
Giulio Francolini, Michele Ganovelli, Vanessa Di Cataldo, Beatrice Detti, Saverio Caini, Mauro Loi, Gabriele Simontacchi, Isacco Desideri, Daniela Greto, Marianna Valzano, Sergio Serni, Luca Vaggelli, Viola Salvestrini, Luca Visani, Carlotta Becherini, Emanuela Olmetto, Ciro Franzese, Davide Baldaccini, Marta Scorsetti, Martina Sollini, Arturo Chiti, Icro Meattini, Richard K. Valicenti, Lorenzo Livi
Publikováno v:
Clinical & experimental metastasis, vol 40, iss 2
PSICHE (NCT05022914) is a prospective trial to test a [68Ga]Ga- PSMA-11 PET/CT imaging tailored strategy. All evaluable patients had biochemical relapse after surgery and underwent centralized [68Ga]Ga-PSMA-11 PET/CT imaging. The treatment was perfor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7c07e7fda156e6f3e519604bf13d958
https://escholarship.org/uc/item/26c8w6z0
https://escholarship.org/uc/item/26c8w6z0
Autor:
C. Wright, Richard K. Valicenti, Ruben C Fragoso, Shyam Rao, Zilong Yuan, Stanley H Benedict, Jianfeng Qiu, Yi Rong, Chithra Kumaran Nair
Publikováno v:
Technology in Cancer Research & Treatment
This work evaluated a commercial fallback planning workflow designed to provide cross-platform treatment planning and delivery. A total of 27 helical tomotherapy intensity-modulated radiotherapy plans covering 4 anatomical sites were selected, includ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c81759c80d7fda64941420d705678106
https://escholarship.org/uc/item/4xn0r5fz
https://escholarship.org/uc/item/4xn0r5fz
Autor:
Charles Catton, W. Robert Lee, Seth A. Rosenthal, Mark A. Ritter, William U. Shipley, Thomas M. Pisansky, Mack Roach, Richard K. Valicenti, Michael I. Seider, Jeff M. Michalski, Howard M. Sandler, Anthony L. Zietman, Colleen A. Lawton, Deborah A. Kuban, I. ElNaqa
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 74:377-382
We conducted a comparative study of clinical target volume (CTV) definition of pelvic lymph nodes by multiple genitourinary (GU) radiation oncologists looking at the levels of discrepancies amongst this group.Pelvic computed tomography (CT) scans fro
Autor:
Deborah A. Kuban, Thomas M. Pisansky, Patrick A. Kupelian, Michael J. Zelefsky, Mary Feng, Theodore L. DeWeese, Howard M. Sandler, Jeff M. Michalski, Alexandra L. Hanlon, Larry L. Kestin, Charles Catton, Richard K. Valicenti, Alan Pollack
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 68:1417-1423
Purpose: To determine the rate and magnitude of late genitourinary (GU) and gastrointestinal (GI) toxicities after salvage or adjuvant radiotherapy (RT) for prostate cancer, and to determine predictive factors for these toxicities. Methods and Materi
Autor:
Arthur T. Porter, William U. Shipley, Harmar D. Brereton, Howard M. Sandler, Seth A. Rosenthal, Gerald E. Hanks, Richard K. Valicenti, Michelle DeSilvio
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 66:1064-1071
We evaluated whether posttreatment prostatic-specific antigen doubling time (PSADT) was predictive of prostate cancer mortality by testing the Prentice requirements for a surrogate endpoint.We analyzed posttreatment PSA measurements in a cohort of 1,
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 58:1093-1097
Purpose To evaluate, in Gleason score 7, pT3N0 prostate cancer patients with positive surgical margins, the predictors of progression-free survival and to identify a patient subgroup that would benefit from immediate adjuvant postoperative radiothera
Autor:
James A. Purdy, Richard K. Valicenti, Srinivasan Vijayakumar, Jeff M. Michalski, Kathryn Winter, Howard M. Sandler, James D. Cox, Walter Bosch
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 57:614-620
Purpose This study determines the effect on toxicity of adding neoadjuvant hormonal therapy (NHT) to three-dimensional conformal radiation therapy (3D-CRT) in RTOG 94-06. Methods Between August 1994 and February 2000, 583 eligible prostate cancer pat
Autor:
M. DeSilvio, Charles R. Thomas, M. Rotman, Sucha O. Asbell, Seunggu J. Han, Richard K. Valicenti, C. Lawton, Mitchell Machtay, Valery Uhl, Mack Roach, M. J. Seider, W. S. Shipley, C. Jones
Publikováno v:
Journal of Clinical Oncology. 21:1904-1911
Purpose: This trial tested the hypothesis that combined androgen suppression (CAS) and whole-pelvic (WP) radiotherapy (RT) followed by a boost to the prostate improves progression-free survival (PFS) by 10% compared with CAS and prostate-only (PO) RT
Publikováno v:
Journal of Urology. 168:2499-2504
Purpose: The risk of erectile dysfunction can influence treatment decisions for localized prostate cancer. To estimate the risk from 2 popular radiotherapies we compared erectile function and overall satisfaction with sexual function after 3-dimensio
Autor:
Craig J. Newschaffer, S. Grant Mulholland, Mohammed Ismail, Leonard G. Gomella, Steve E Strup, Adam P. Dicker, Richard K. Valicenti, Robert O. Petersen
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 45:53-58
This study examines the effect of adjuvant radiation therapy (RT) on outcome in patients with pT3N0 prostate cancer and makes comparisons to a matched control group.At our center, 149 patients undergoing radical prostatectomy were found to have pT3N0